Home > Boards > US Listed > Medical - Drugs > Cybin Inc. (CYBN)

Check out the Emerging Growth / InvestorsHub Conference

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NewsWire[Tiffany] Member Profile
Member Level 
Followed By 1
Posts 12
Boards Moderated 1
Alias Born 07/29/19
160x600 placeholder
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/23/2021 11:48:43 AM
Cybin Inc reports Q2 results Seeking Alpha - 11/15/2021 8:41:39 AM
Cybin Inc. Reports its Second Quarter Financial Results and Recent Business Highlights InvestorsHub NewsWire - 11/15/2021 8:31:04 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/15/2021 7:33:31 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/12/2021 2:50:52 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/9/2021 1:22:49 PM
Cybin target raised at Oppenheimer after psilocybin data from Compass Pathways Seeking Alpha - 11/9/2021 10:15:27 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/8/2021 11:32:03 AM
Cybin Announces Positive CYB003 Data Demonstrating Significant Advantages Over Oral Psilocybin for Treatment of Mental Health InvestorsHub NewsWire - 11/8/2021 8:29:11 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/4/2021 11:49:54 AM
Cybin Granted DEA Schedule I Manufacturing License InvestorsHub NewsWire - 11/4/2021 7:46:42 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/2/2021 11:03:34 AM
Cybin Hosting Research and Development Briefing on November 8, 2021 InvestorsHub NewsWire - 11/2/2021 9:13:12 AM
Breaking the Habit: Psychedelic Stigma Fades as Research Points to Critical Use in Smoking Cessation and More NetworkNewsWire - 11/1/2021 8:45:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/26/2021 12:09:44 PM
Cybin Announces FDA Investigational New Drug Authorization of Cybin's Sponsored Feasibility Study Using Kernel Flow Technology InvestorsHub NewsWire - 10/26/2021 9:44:13 AM
2 “Strong Buy” Penny Stocks That Could Spike Over 200% TipRanks - 10/20/2021 11:04:47 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/12/2021 3:55:26 PM
Cybin Files an International Patent Application Covering Psychedelic Delivery Methods InvestorsHub NewsWire - 10/12/2021 9:23:03 AM
Cybin Develops Novel Psychedelic Treatments TipRanks - 10/8/2021 9:22:49 AM
Cybin Develops Dovel Psychedelic Treatments TipRanks - 10/8/2021 9:22:49 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/7/2021 2:56:36 PM
Appointment of Agent for Service of Process and Undertaking (f-x) Edgar (US Regulatory) - 10/4/2021 6:01:44 AM
Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10) Edgar (US Regulatory) - 10/1/2021 5:29:45 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/27/2021 12:22:32 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences